Latest Articles
-
RMD, MDT Top Revvity Stock on Price & Potential
RMD, MDT are Revvity’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/OpInc) compared to Revvity stock 2) But higher revenue and operating income growth This disconnect between valuation and performance could mea...
-
Large Cap Stocks Trading At 52-Week High
As on Monday, October 6, 35 Large Cap stocks from the Russell 3000 are trading at their 52-week highs. Among these stocks, Micron Technology (MU) has outpaced the rest in the last one month, generating a robust 45% return over this period. Stock...
-
Ten-Year Tally: MDT Hands Back $52 Bil to Shareholders
In the last decade, Medtronic (MDT) has returned a notable $52 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the market’...
-
Large Cap Stocks Trading At 52-Week High
As on Thursday, August 21, 18 Large Cap stocks from the Russell 3000 are trading at their 52-week highs. Among these stocks, Alnylam Pharmaceuticals (ALNY) has outpaced the rest in the last one month, generating a robust 41% return over this peri...
-
S&P 500 Movers | Winners: ADI, MCK, MDT | Losers: INTC, TGT, DELL
On Wednesday, August 20, markets stayed flat overall, as seen in the S&P 500 falling 0.24%, the Dow 30 remaining flat, and the Nasdaq 100 falling 0.58%. Still, certain stocks experienced more movement than the indices suggested. List ...
-
How To Trade Medtronic Stock Ahead of Its Earnings?
Medtronic (NYSE:MDT) is scheduled to report its earnings on Tuesday, August 19, 2025. Analysis of the last five years of data reveals that Medtronic’s stock performance on the day after its earnings release is highly unpredictable. The stoc...
-
S&P 500 Stocks Trading At 52-Week High
As on Saturday, August 16, 7 of the S&P 500 stocks are trading at their 52-week highs. Among these stocks, Incyte (INCY) has outpaced the rest in the last one month, generating a robust 26% return over this period. Stocks At 52W Highs Belo...
-
Better Bet Than Medtronic Stock: Pay Less To Get More From LIVN, CNMD
LIVN, CNMD are MDT’s peers in Health Care Equipment industry that have: 1) Lower valuation (P/EBIT) compared to MDT 2) But higher revenue and operating income growth This disconnect between valuation and performance could mean that you ar...
-
Medtronic Stock To $50?
Medtronic (NYSE:MDT), best known for developing the world’s first battery-powered implantable pacemaker, has over the years been respected as a global leader in medical technology and has created tremendous value for its investors. While the comp...
-
Will Medtronic Stock Rise When It Reports Earnings?
Medtronic (NYSE:MDT) is set to report its earnings on Wednesday, May 21, 2025. Over the past five years, Medtronic’s stock has experienced a positive one-day return following its earnings announcements in 53% of cases. These positive return...
-
After A Mixed Q3 Where Does Medtronic Stock Go From Here?
Medtronic (NYSE: MDT) recently announced its Q3 fiscal 2025 results (fiscal ends in April), reporting revenue of $8.29 billion, slightly below the $8.33 billion consensus estimate. Adjusted earnings per share of $1.39 modestly exceeded the ex...
-
How Might Medtronic Stock React To Upcoming Earnings?
Medtronic (NYSE:MDT) is set to report its earnings on Feb 18, 2025. While a lot will depend on how results stack up against consensus and expectations, understanding historical patterns might just turn the odds in your favor if you are an event-d...
-
What’s Next For Medtronic Stock?
Medtronic (NYSE: MDT) reported its Q2 fiscal 2025 results (fiscal ends in April) last week, with revenues and earnings exceeding the street estimates. The company reported revenue of $8.4 billion and adjusted earnings of $1.26 per share, compa...
-
Why Abbott Stock Looks More Attractive Than Its Medical Devices Peer
Given its better prospects, we believe Abbott stock (NYSE: ABT) is a better pick than its peer Medtronic stock (NYSE: MDT). ABT stock trades at 4.9x trailing revenues, versus 3.6x for MDT. Although Medtronic is slightly more profitable, Abbot...
-
What’s Next For Medtronic Stock After An Upbeat Q1?
Medtronic (NYSE: MDT) recently reported its Q1 fiscal 2025 results (fiscal ends in April), with revenues and earnings exceeding our estimates . The company reported revenue of $7.9 billion and adjusted earnings of $1.23 per share, compared to ...
